These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19391257)

  • 1. More on reports of esophageal cancer with oral bisphosphonate use.
    Shaheen NJ
    N Engl J Med; 2009 Apr; 360(17):1790-1; author reply 1791-2. PubMed ID: 19391257
    [No Abstract]   [Full Text] [Related]  

  • 2. Reports of esophageal cancer with oral bisphosphonate use.
    Wysowski DK
    N Engl J Med; 2009 Jan; 360(1):89-90. PubMed ID: 19118315
    [No Abstract]   [Full Text] [Related]  

  • 3. More on reports of esophageal cancer with oral bisphosphonate use.
    Robins HI; Holen KD
    N Engl J Med; 2009 Apr; 360(17):1790; author reply 1791-2. PubMed ID: 19391256
    [No Abstract]   [Full Text] [Related]  

  • 4. More on reports of esophageal cancer with oral bisphosphonate use.
    Siris ES; Oster MW; Bilezikian JP
    N Engl J Med; 2009 Apr; 360(17):1791; author reply 1791-2. PubMed ID: 19391259
    [No Abstract]   [Full Text] [Related]  

  • 5. More on reports of esophageal cancer with oral bisphosphonate use.
    Hofbauer LC; Miehlke S
    N Engl J Med; 2009 Apr; 360(17):1790; author reply 1791-2. PubMed ID: 19391258
    [No Abstract]   [Full Text] [Related]  

  • 6. More on reports of esophageal cancer with oral bisphosphonate use.
    Solomon DH; Patrick A; Brookhart MA
    N Engl J Med; 2009 Apr; 360(17):1789-90; author reply 1791-2. PubMed ID: 19391255
    [No Abstract]   [Full Text] [Related]  

  • 7. More on reports of esophageal cancer with oral bisphosphonate use.
    Abrahamsen B; Eiken P; Eastell R
    N Engl J Med; 2009 Apr; 360(17):1789; author reply 1791-2. PubMed ID: 19387022
    [No Abstract]   [Full Text] [Related]  

  • 8. Alendronate and risk of esophageal cancer: a nationwide population-based study in Taiwan.
    Chen YM; Chen DY; Chen LK; Tsai YW; Chang LC; Huang WF; Chen LK; Liu CL; Chen YT; Hsiao FY
    J Am Geriatr Soc; 2011 Dec; 59(12):2379-81. PubMed ID: 22188086
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral bisphosphonates and oesophageal cancer.
    Wysowski DK
    BMJ; 2010 Sep; 341():c4506. PubMed ID: 20813821
    [No Abstract]   [Full Text] [Related]  

  • 10. An evaluation of the use of oral bisphosphonates and risk of esophageal cancer.
    Haber SL; McNatty D
    Ann Pharmacother; 2012 Mar; 46(3):419-23. PubMed ID: 22333262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atrial fibrillation during bisphosphonate therapy. side effects or coincidental finding?].
    Ringe JD
    MMW Fortschr Med; 2009 Mar; 151(10):7. PubMed ID: 19472655
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of the gastrointestinal effects of the nitrogen-containing bisphosphonates pamidronate, alendronate, and olpadronate in humans.
    Twiss IM; van den Berk AH; de Kam ML; Bosch JJ; Cohen AF; Vermeij P; Burggraaf J
    J Clin Pharmacol; 2006 Apr; 46(4):483-7. PubMed ID: 16554458
    [No Abstract]   [Full Text] [Related]  

  • 13. [Alendronate-induced severe esophagitis. A rare and severe reversible side-effect illustrated by three case reports].
    Tóth E; Fork FT; Lindelöw K; Lindström E; Verbaan H; Veress B
    Lakartidningen; 1998 Aug; 95(35):3676-80. PubMed ID: 9748782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An esophageal ulcer mimicking advanced esophageal cancer in a patient on alendronate sodium treatment for osteoporosis.
    Terashima T; Hiramatsu K; Shimatani A; Matsuda M; Ogino H; Satomura Y; Noda Y
    Endoscopy; 2006; 38 Suppl 2():E37. PubMed ID: 17366400
    [No Abstract]   [Full Text] [Related]  

  • 15. More on atypical fractures of the femoral diaphysis.
    Lee P; Seibel MJ
    N Engl J Med; 2008 Jul; 359(3):317; author reply 317-8. PubMed ID: 18642421
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathological fractures in patients caused by bisphosphonate-related osteonecrosis of the jaws: report of 3 cases.
    Wongchuensoontorn C; Liebehenschel N; Wagner K; Fakler O; Gutwald R; Schmelzeisen R; Sauerbier S
    J Oral Maxillofac Surg; 2009 Jun; 67(6):1311-6. PubMed ID: 19446222
    [No Abstract]   [Full Text] [Related]  

  • 17. A compounded diagnosis: maxillary osteochemonecrosis in the setting of low dose radiotherapy.
    Magliocca KR; Stavropoulos MF; Bhattacharyya I; Cohen DM
    J Oral Maxillofac Surg; 2009 May; 67(5):1138-40. PubMed ID: 19375031
    [No Abstract]   [Full Text] [Related]  

  • 18. [Esophageal lesions associated with diphosphonates].
    Larsen KO; Stray N; Engh V; Sandnes D
    Tidsskr Nor Laegeforen; 2000 Aug; 120(20):2397-9. PubMed ID: 11475224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of bisphosphonates in women of child bearing age.
    McKenna M; Mansfield JC
    Aliment Pharmacol Ther; 2009 Jun; 29(11):1214-5; author reply 1215-6. PubMed ID: 19473128
    [No Abstract]   [Full Text] [Related]  

  • 20. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.
    French DD; Margo CE
    Retina; 2008 Jun; 28(6):889-93. PubMed ID: 18536608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.